Skip to main content Skip to megamenu (after main content)
Improving human health through Biomedical innovation and discovery.

Bioserve India to sponsor webinar hosted by the Society of Fetal Medicine

Hyderabad India – 15 September 2021: Bioserve Biotechnologies India Pvt. Ltd. (a 100% owned subsidiary of REPROCELL Inc) will sponsor a webinar series hosted by the Society of Fetal Medicine in September. The title of the webinar is “Genetic Testing in Fetal Medicine-Navigating the Maze”.

Under the PRENITA Brand, Bioserve Biotechnologies India Pvt Ltd offers a range of prenatal and post-natal screening tests that provide accurate results with actionable insights, helping clinicians to analyze and provide the best outcome for patients. PRENITA provides the most advanced Preimplantation Genetic Screening/Diagnosis (PGS/PGD), Non-Invasive Prenatal Screening Test (NIPT), Invasive Diagnostic testing, Carrier Screening, and Single Gene Panels.

The webinar will take place on Wednesday 22nd September 2021, from 8:00 PM onwards

For more information, phone +91 40 2955 8178/+91 40 2955 8176, email bioserve.india@reprocell.com/Prenita.Test@reprocell.com, or visit the company website at https://bioserve.in/